One Year of COVID-19 Infection in Iraq and EMR Countries One Year of COVID-19 Infection in Iraq and EMR Countries
Main Article Content
Keywords
Covid 19, corona virus, Iraq, EMRO countries
Abstract
Background : COVID-19 pandemic affected the world for the last 20 months (January 2020-August 2021. It was troublesome, devestating in terms of cases, deaths and socioeconomic consequences and unpredictable in behaviour.
Objectives : To document comparative profile of the COVID -19 in Iraq and other Eastern Mediterranean Countries in terms of time trend and three epidemiological parameters ( incidence, case fatality and mortality rates).
Methods : A record-based prospective study. Data were checked daily throughout the study period from February 21, 2020 through February 23, 2021. The targeted numbers were recorded on an excel sheet or word table and updated daily over the specified period. The data covered the period from the onset of the pandemic in various countries. Data included the daily new cases of COVID-19 reported by various government agencies and Ministries of Health in the region supported by two private websites. The multiple sources used assured cross-matching of reported figures and a very high degree of consistency was achieved.
Results: The annual incidence rate, case fatality ratio and cause specific mortality rate in Iraq were 17,636.8 per million, 1.97% and 347.3 per million in that order. These three rates were very variable among various Eastern Mediterranean Countries.
Conclusion : Iraq and other Countries in the region were harshly struck by COVID-19. Extensive variation in the major epidemiological parameters were documented. The pandemic uncovered major defects in the health care systems and still awaiting a hope to contain this unpredictable event.
References
1. WHO, Regional Office for Europe. Coronavirus disease (COVID-19) outbreak. Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19 Accessed on October 17, 2020
2. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMoa2002032. [Epub ahead of print]
3. Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery 2020; 76: 71-76.
4. Sohrabi C, Alsafi Z, O,Neilla N, Khan M, Kerwan A, Al-Jabir A. et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery 2020; 76: 71-76.
5. Howell B. The Countries Who've Handled Coronavirus the Best – and Worst. Last updated on 26 Apr 2021. Available from: https://www.movehub.com/blog/best-and-worst-covid-responses/ Accessed on April 29, 2021.
6. Habib OS, Abdul-Wahid DA, Khudair NS, Mohammed NQ, Al-Hilfi RA. The Pandemic of COVID-19 in Eastern Mediterranean Region: Selected Outcome Parameters. The Medical Journal of Basrah University 2020; 38 (2):
7. Rawaf S, Yamamoto HQ, Rawaf D. Unlocking towns and cities: COVID-19 exit strategy. East Mediterr Health J. 2020 26(5):499-502.
8. Angulo FJ, Finelli L, Swerdlow SL. Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level. JAMA. 2020;323(22):2247-2248. doi:10.1001/jama.2020.7872.
9. Ganatra S, Hammond SP, Nohria A. The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer 2020.
10. Habib OS, AlKanan AK, Abed AH, Mohammed NQ. Epidemiological features of COVID-19 epidemic in Basrah province-southern Iraq-First report. The Medical Journal of Basrah University 2020; 38 (1): 6-17.
11. Al-Hijjaj BA, Al-Rubaye AK, Al-Hashim ZT, Mohammed MA, Habib OS. A study on 696 COVID-19 cases in Basrah-Southern Iraq: Severity and outcome indicators. IqNJM 2020; 2 (3-COVID-19 Special Issue):19-26.
12. Hachim IY, Hachim MY, Naeem KB, Hannawi H, Al Salmi I, Hannawi S. Male Gender is A Risk Factor For Sever Form of COVID-19 Illness and Worse Outcome in The Middle East. Research Square 2020.
13. Al-kuraishy HM, Al-Maiahy TJ, Al-Gareeb AI, Musa RA, Ali ZH. COVID-19 pneumonia in an Iraqi pregnant woman with preterm delivery. Asian Pacific Journal of Reproduction 2020;9(3):156.
14. Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, Gilboa SM. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–June 7, 2020. Morbidity and Mortality Weekly Report 2020; 69(25):769.
15. Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K. COVID-19 and ethnicity: a novel pathophysiological role for inflammation. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020;14(5):1043-1051.
16. Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID-19?. Journal of Microbiology, Immunology, and Infection 2020.
17. Han MS, Seong MW, Kim N, Shin S, Cho SI, Park H, Choi EH. Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19, Seoul, South Korea. Emerging infectious diseases 2020;26(10):2497-2499.
18. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 among children in China. Pediatrics 2020;145(6)
19. Ad’hiah AH, Allami RH, Mohsin RH, Abdullah MH, AL-Sa’ady AJ, Alsudani MY. Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients. Egyptian Journal of Medical Human Genetics 2020;21(1): 1-6.
20. Karimzadeh S, Bhopal R, Tien HN. Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses. Epidemiol Infect 2021 April 14;149:e96. doi: 10.1017/S0950268821000790.
21. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. Jama 2020;323(14):1406-1407.
22. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Lessler J. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of internal medicine 2020;172(9):577-582.
23. Burke RM, Killerby ME, Newton S, Ashworth CE, Berns AL, Brennan S, Lewis NM. Symptom profiles of a convenience sample of patients with covid-19—United States, January–April 2020. Morbidity and Mortality Weekly Report 2020;69(28): 904.
24. Hopkins C, Surda P, Kumar N. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology 2020;58 (3): 295-298
25. Snider B, Patel B, McBean E. Asymptomatic Cases, the Hidden Challenge in Predicting COVID-19 Caseload Increases. Infect.Dis. Rep. 2021, 13, 340–347. https://doi.org/10.3390/idr13020033
26. Kronbichler A, Kresse D, Yoon S, Lee KH, Effenberger M, Shin JI. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis. International journal of infectious diseases 2020;98:180-186.
27. Dye C, Cheng RCH, Daqpunar JS, Williams BG. The scale and dynamics of COVID-19
28. epidemics across Europe. Royal Society Open Science 2020; 7 (11):
29. https://doi.org/10.1098/rsos.201726 Day M. Covid-19: four fifths of cases are asymptomatic, China figures indicate. 2020 (Published 02 April 2020)Cite this as: BMJ 2020;369:m1375.available from: https://doi.org/10.1136/bmj.m1375.
30. Slifka MK, Gao L. Is presymptomatic spread a major contributor to COVID-19 transmission?. Nature Medicine 2020; 26(10): 1531-1533.
31. Timeline: WHO response to COVID-19 Available from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline Accessed on 4 May 2021.
32. Al-Tammemi A.B. The battle against COVID-19 in Jordan: an early overview of the Jordanian experience. Frontiers in Public Health 2020;00188.
33. Hashim BM, Al-Naseri SK, Al-Maliki A, Al-Ansari N. Impact of COVID-19 lockdown on NO2, O3, PM2. 5 and PM10 concentrations and assessing air quality changes in Baghdad, Iraq. Science of the Total Environment 2020;754:141978.
34. De Deyn MLZQ, Ng QX, Loke W, Yeo WS. A tale of two cities: A comparison of Hong Kong and Singapore's early strategies for the Coronavirus Disease 2019 (COVID-19). Journal of Infection 2020; 81(3): e51-e52.
35. Lounis M. COVID-19 in Algeria: Chronology and evaluation of preventive actions. European Journal of Medical and educational Technologies 2020; 13(1):em2001
36. Bavel, J.J.V., Baicker, K., Boggio, P.S. et al. Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav 2020; 4, 460–471. https://doi.org/10.1038/s41562-020-0884-z.
37. Jebril N. Impact of the COVID-19 Pandemic on the environment–A case study of Iraq. Available at SSRN 3597426.
38. Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, Khosrawipour T. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. Journal of travel medicine 2020; 27(3): taaa037.
39. VoPham T, Weaver MD, Hart JE, Ton M, White E, Newcomb PA. Effect of social distancing on COVID-19 incidence and mortality in the US. MedRxiv 2020.
40. Kwok KO, Li KK, Chan HH, Yi YY, Tang A, Wei WI, Wong SY. Community responses during early phase of covid-19 epidemic, Hong Kong. Emerg Infect Dis 2020;26(7):10-3201. Was 55.
41. Aziz PY, Hadi JM, Aram MS, Aziz SB, Rahman HS, Ahmed HA, Ali SMA. The strategy for controlling COVID-19 in Kurdistan Regional Government (KRG)/Iraq: identification, epidemiology, transmission, treatment, and recovery. International Journal of Surgery Open 2020; 25:41-46.
42. WHO. WHO Coronavirus Disease (COVID-19) Dashboard. Available from: https://covid19.who.int/table Accessed daily from February 21 to October 31, 2020..
43. WHO, Regional Office for the Eastern Mediterranean: COVID-19 daily updates. Available from: http://twitter.com/whoemro/status/1311714137009983488?s=24 Accessed daily from March 21, 2020 to February 23, 2021.
44. Corona Worldometers. A website displaying figures on COVID-19 Infection at global level on daily basis. World Health Organization. Available from: https://www.worldometers.info/coronavirus/ Accessed: Daily from February 21,2020 t0 February 23, 2021.
45. https://www. sehhty.com/ Accessed: Daily from March 24 to February 23, 2021.
46. Worldometer (www.Worldometers.info). Elaboration of data by United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2019 Revision. (Medium-fertility variant). Available from: https://www.worldometers.info/population/ Accessed on April 18, 2020.)
47. Gordis L. Epidemiology. 5th Edition. USA, Johns Hopkins University School of Medicine: Elsevier Saunders, 2014.
48. COVID-19 pandemic in New York (state). The free encyclopedia. Available from https://en.wikipedia.org/wiki/COVID-19_pandemic_in_New_York_(state) Accessed on September 1, 2021
49. How epidemiology has shaped the COVID pandemic (Editorial). Nature. 2021 Jan;589(7843):491-492. doi: 10.1038/d41586-021-00183-z. PMID: 33505041. Accessed on June 29, 2021
50. Gupta, A, Baneriee S, Das S. Significance of geographical factors to the COVID-19 outbreak in India. Model Earth Syst Environ. 2020 Jun 17 : 1–9. doi: 10.1007/s40808-020-00838-2 [Epub ahead of print].
51. Bellali H, Chtioui N, Chahed M. Factors associated with country-variation in COVID-19 morbidity and mortality worldwide: an observational geographic study COVID-19 morbidity and mortality country-variation. medRxiv 2020.05.27.20114280; doi: https://doi.org/10.1101/2020.05.27.20114280.
52. Allcott, H, Boxell L, CornwayJC, Furguson BA, Gentzkow M, Goldman B. What explains temporal and geographic variation in the early US Coronavirus pandemic? What explains temporal and geographic variation in the early US Coronavirus pandemic? Working Paper 27965 http://www.nber.org/papers/w27965 National Beareu of Economic Research 1050 Massachusetts Avenue Cambridge, MA 02138 October 2020, Revised November 2020. Available from https://www.nber.org/system/files/working_papers/w27965/w27965.pdf Accessed on July 10, 2021
53. Kulu, H, Dorey P. Infection rates from Covid-19 in Great Britain by geographical units: A model-based estimation from mortality data. Health & Place 2021; 67: 102460.
54. Sorci, G., Faivre, B. & Morand, S. Explaining among-country variation in COVID-19 case fatality rate. Sci Rep 10, 18909 (2020). https://doi.org/10.1038/s41598-020-75848-2
55. Liu Y, He Z, Zhou X. Space-Time Variation and Spatial Differentiation of COVID-19 Confirmed Cases in Hubei Province Based on Extended GWR. Int. J. Geo-Inf. 2020, 9(9), 536; https://doi.org/10.3390/ijgi9090536.
56. Castro MC, Kim S, Barberia L, Ribeiro AF, Gurzenda S, Ribeiro KB et al. Spatiotemporal pattern of COVID-19 spread in Brazil. Science 2021; 372(6544): 821-826. DOI: 10.1126/science.abh1558.
57. Al-Wahaibi N, Al-Maskar M, Al-Dhahli B, Al-Issaei H, Al-Bahlani S. A review of the prevalence of COVID-19 in the Arab world. J Infect Dev Ctries 2020; 14 (11): 1238-1245. doi: 10.3855/jidc.13270
2. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Feb 28. doi: 10.1056/NEJMoa2002032. [Epub ahead of print]
3. Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery 2020; 76: 71-76.
4. Sohrabi C, Alsafi Z, O,Neilla N, Khan M, Kerwan A, Al-Jabir A. et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery 2020; 76: 71-76.
5. Howell B. The Countries Who've Handled Coronavirus the Best – and Worst. Last updated on 26 Apr 2021. Available from: https://www.movehub.com/blog/best-and-worst-covid-responses/ Accessed on April 29, 2021.
6. Habib OS, Abdul-Wahid DA, Khudair NS, Mohammed NQ, Al-Hilfi RA. The Pandemic of COVID-19 in Eastern Mediterranean Region: Selected Outcome Parameters. The Medical Journal of Basrah University 2020; 38 (2):
7. Rawaf S, Yamamoto HQ, Rawaf D. Unlocking towns and cities: COVID-19 exit strategy. East Mediterr Health J. 2020 26(5):499-502.
8. Angulo FJ, Finelli L, Swerdlow SL. Reopening Society and the Need for Real-Time Assessment of COVID-19 at the Community Level. JAMA. 2020;323(22):2247-2248. doi:10.1001/jama.2020.7872.
9. Ganatra S, Hammond SP, Nohria A. The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer 2020.
10. Habib OS, AlKanan AK, Abed AH, Mohammed NQ. Epidemiological features of COVID-19 epidemic in Basrah province-southern Iraq-First report. The Medical Journal of Basrah University 2020; 38 (1): 6-17.
11. Al-Hijjaj BA, Al-Rubaye AK, Al-Hashim ZT, Mohammed MA, Habib OS. A study on 696 COVID-19 cases in Basrah-Southern Iraq: Severity and outcome indicators. IqNJM 2020; 2 (3-COVID-19 Special Issue):19-26.
12. Hachim IY, Hachim MY, Naeem KB, Hannawi H, Al Salmi I, Hannawi S. Male Gender is A Risk Factor For Sever Form of COVID-19 Illness and Worse Outcome in The Middle East. Research Square 2020.
13. Al-kuraishy HM, Al-Maiahy TJ, Al-Gareeb AI, Musa RA, Ali ZH. COVID-19 pneumonia in an Iraqi pregnant woman with preterm delivery. Asian Pacific Journal of Reproduction 2020;9(3):156.
14. Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, Gilboa SM. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–June 7, 2020. Morbidity and Mortality Weekly Report 2020; 69(25):769.
15. Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K. COVID-19 and ethnicity: a novel pathophysiological role for inflammation. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020;14(5):1043-1051.
16. Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID-19?. Journal of Microbiology, Immunology, and Infection 2020.
17. Han MS, Seong MW, Kim N, Shin S, Cho SI, Park H, Choi EH. Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19, Seoul, South Korea. Emerging infectious diseases 2020;26(10):2497-2499.
18. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 among children in China. Pediatrics 2020;145(6)
19. Ad’hiah AH, Allami RH, Mohsin RH, Abdullah MH, AL-Sa’ady AJ, Alsudani MY. Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients. Egyptian Journal of Medical Human Genetics 2020;21(1): 1-6.
20. Karimzadeh S, Bhopal R, Tien HN. Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses. Epidemiol Infect 2021 April 14;149:e96. doi: 10.1017/S0950268821000790.
21. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. Jama 2020;323(14):1406-1407.
22. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Lessler J. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of internal medicine 2020;172(9):577-582.
23. Burke RM, Killerby ME, Newton S, Ashworth CE, Berns AL, Brennan S, Lewis NM. Symptom profiles of a convenience sample of patients with covid-19—United States, January–April 2020. Morbidity and Mortality Weekly Report 2020;69(28): 904.
24. Hopkins C, Surda P, Kumar N. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology 2020;58 (3): 295-298
25. Snider B, Patel B, McBean E. Asymptomatic Cases, the Hidden Challenge in Predicting COVID-19 Caseload Increases. Infect.Dis. Rep. 2021, 13, 340–347. https://doi.org/10.3390/idr13020033
26. Kronbichler A, Kresse D, Yoon S, Lee KH, Effenberger M, Shin JI. Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis. International journal of infectious diseases 2020;98:180-186.
27. Dye C, Cheng RCH, Daqpunar JS, Williams BG. The scale and dynamics of COVID-19
28. epidemics across Europe. Royal Society Open Science 2020; 7 (11):
29. https://doi.org/10.1098/rsos.201726 Day M. Covid-19: four fifths of cases are asymptomatic, China figures indicate. 2020 (Published 02 April 2020)Cite this as: BMJ 2020;369:m1375.available from: https://doi.org/10.1136/bmj.m1375.
30. Slifka MK, Gao L. Is presymptomatic spread a major contributor to COVID-19 transmission?. Nature Medicine 2020; 26(10): 1531-1533.
31. Timeline: WHO response to COVID-19 Available from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline Accessed on 4 May 2021.
32. Al-Tammemi A.B. The battle against COVID-19 in Jordan: an early overview of the Jordanian experience. Frontiers in Public Health 2020;00188.
33. Hashim BM, Al-Naseri SK, Al-Maliki A, Al-Ansari N. Impact of COVID-19 lockdown on NO2, O3, PM2. 5 and PM10 concentrations and assessing air quality changes in Baghdad, Iraq. Science of the Total Environment 2020;754:141978.
34. De Deyn MLZQ, Ng QX, Loke W, Yeo WS. A tale of two cities: A comparison of Hong Kong and Singapore's early strategies for the Coronavirus Disease 2019 (COVID-19). Journal of Infection 2020; 81(3): e51-e52.
35. Lounis M. COVID-19 in Algeria: Chronology and evaluation of preventive actions. European Journal of Medical and educational Technologies 2020; 13(1):em2001
36. Bavel, J.J.V., Baicker, K., Boggio, P.S. et al. Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav 2020; 4, 460–471. https://doi.org/10.1038/s41562-020-0884-z.
37. Jebril N. Impact of the COVID-19 Pandemic on the environment–A case study of Iraq. Available at SSRN 3597426.
38. Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Schubert J, Bania J, Khosrawipour T. The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China. Journal of travel medicine 2020; 27(3): taaa037.
39. VoPham T, Weaver MD, Hart JE, Ton M, White E, Newcomb PA. Effect of social distancing on COVID-19 incidence and mortality in the US. MedRxiv 2020.
40. Kwok KO, Li KK, Chan HH, Yi YY, Tang A, Wei WI, Wong SY. Community responses during early phase of covid-19 epidemic, Hong Kong. Emerg Infect Dis 2020;26(7):10-3201. Was 55.
41. Aziz PY, Hadi JM, Aram MS, Aziz SB, Rahman HS, Ahmed HA, Ali SMA. The strategy for controlling COVID-19 in Kurdistan Regional Government (KRG)/Iraq: identification, epidemiology, transmission, treatment, and recovery. International Journal of Surgery Open 2020; 25:41-46.
42. WHO. WHO Coronavirus Disease (COVID-19) Dashboard. Available from: https://covid19.who.int/table Accessed daily from February 21 to October 31, 2020..
43. WHO, Regional Office for the Eastern Mediterranean: COVID-19 daily updates. Available from: http://twitter.com/whoemro/status/1311714137009983488?s=24 Accessed daily from March 21, 2020 to February 23, 2021.
44. Corona Worldometers. A website displaying figures on COVID-19 Infection at global level on daily basis. World Health Organization. Available from: https://www.worldometers.info/coronavirus/ Accessed: Daily from February 21,2020 t0 February 23, 2021.
45. https://www. sehhty.com/ Accessed: Daily from March 24 to February 23, 2021.
46. Worldometer (www.Worldometers.info). Elaboration of data by United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2019 Revision. (Medium-fertility variant). Available from: https://www.worldometers.info/population/ Accessed on April 18, 2020.)
47. Gordis L. Epidemiology. 5th Edition. USA, Johns Hopkins University School of Medicine: Elsevier Saunders, 2014.
48. COVID-19 pandemic in New York (state). The free encyclopedia. Available from https://en.wikipedia.org/wiki/COVID-19_pandemic_in_New_York_(state) Accessed on September 1, 2021
49. How epidemiology has shaped the COVID pandemic (Editorial). Nature. 2021 Jan;589(7843):491-492. doi: 10.1038/d41586-021-00183-z. PMID: 33505041. Accessed on June 29, 2021
50. Gupta, A, Baneriee S, Das S. Significance of geographical factors to the COVID-19 outbreak in India. Model Earth Syst Environ. 2020 Jun 17 : 1–9. doi: 10.1007/s40808-020-00838-2 [Epub ahead of print].
51. Bellali H, Chtioui N, Chahed M. Factors associated with country-variation in COVID-19 morbidity and mortality worldwide: an observational geographic study COVID-19 morbidity and mortality country-variation. medRxiv 2020.05.27.20114280; doi: https://doi.org/10.1101/2020.05.27.20114280.
52. Allcott, H, Boxell L, CornwayJC, Furguson BA, Gentzkow M, Goldman B. What explains temporal and geographic variation in the early US Coronavirus pandemic? What explains temporal and geographic variation in the early US Coronavirus pandemic? Working Paper 27965 http://www.nber.org/papers/w27965 National Beareu of Economic Research 1050 Massachusetts Avenue Cambridge, MA 02138 October 2020, Revised November 2020. Available from https://www.nber.org/system/files/working_papers/w27965/w27965.pdf Accessed on July 10, 2021
53. Kulu, H, Dorey P. Infection rates from Covid-19 in Great Britain by geographical units: A model-based estimation from mortality data. Health & Place 2021; 67: 102460.
54. Sorci, G., Faivre, B. & Morand, S. Explaining among-country variation in COVID-19 case fatality rate. Sci Rep 10, 18909 (2020). https://doi.org/10.1038/s41598-020-75848-2
55. Liu Y, He Z, Zhou X. Space-Time Variation and Spatial Differentiation of COVID-19 Confirmed Cases in Hubei Province Based on Extended GWR. Int. J. Geo-Inf. 2020, 9(9), 536; https://doi.org/10.3390/ijgi9090536.
56. Castro MC, Kim S, Barberia L, Ribeiro AF, Gurzenda S, Ribeiro KB et al. Spatiotemporal pattern of COVID-19 spread in Brazil. Science 2021; 372(6544): 821-826. DOI: 10.1126/science.abh1558.
57. Al-Wahaibi N, Al-Maskar M, Al-Dhahli B, Al-Issaei H, Al-Bahlani S. A review of the prevalence of COVID-19 in the Arab world. J Infect Dev Ctries 2020; 14 (11): 1238-1245. doi: 10.3855/jidc.13270
Article Sidebar
Published
Jan 15, 2022
Article Details
How to Cite
1.
One Year of COVID-19 Infection in Iraq and EMR Countries: One Year of COVID-19 Infection in Iraq and EMR Countries. Iraqi Natl J Med [Internet]. 2022 Jan. 15 [cited 2024 Apr. 18];4(1):92-109. Available from: https://www.iqnjm.com/index.php/homepage/article/view/69
Issue
Section
Original Articles
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
How to Cite
1.
One Year of COVID-19 Infection in Iraq and EMR Countries: One Year of COVID-19 Infection in Iraq and EMR Countries. Iraqi Natl J Med [Internet]. 2022 Jan. 15 [cited 2024 Apr. 18];4(1):92-109. Available from: https://www.iqnjm.com/index.php/homepage/article/view/69